Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (229)	11/11/1998 5:15:00 PM
From: scaram(o)uche	Respond to of 1073

>> Worse yet, my own position in OXGN was, alas, entirely too small to matter much << We need to be hybrid-cloned..... my position was fairly nice-sized, but I bailed just after the open, happy with what I thought was a great, quick profit. And, to think, given that the kids didn't need to be up and out to school today (holiday), I could have slept in. Ugh. Hurts to laugh. >> There is no way I belong in the company of << OXGN clearly stood out from the other suggestions made to the thread. It fit with low price:book, and it sounded like a leveraged business plan. A simple Medline showed that at least some of their academic collaborators are serious about their science. It screamed out "new", and there's lots of attention focusing on hypoxic environments and how to mug them.